BRCA2 and cancer: These features are relevant for cancer biology: cancer progression begins in diploid cells and defects in homologous recombination have been implicated in predisposition to tumorigenesis (i.e. BRCA2 mutations, [32,33]) and exploited for anticancer therapies [34–36].